Señales en vivo de VRNA | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 jun 2024 @ 14:47):
Our systems believe the stock currently is overvalued by -0.79% compare to its pairs and should correct downwards.

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs...

Stats
Volumen de hoy	1.11M
Volumen promedio	767 956
Capitalización de mercado	1.26B
EPS	$-0.320 ( Q1 \| 2024-05-10 )
Próxima fecha de ganancias	( $-0.350 ) 2024-08-01
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-18.56 (Sector) 42.63 (Industry) 24.32
ATR14	$0.0250 (0.17%)

AADI -6.47%

ABCL 2.19%

ABCM 0.04%

ABEO -3.08%

ABIO -1.68%

ABOS 4.67%

ABSI 4.93%

ABUS -0.66%

ABVX -1.88%

ACAD -0.10%

ACER -17.95%

ACET -8.50%

ACGN 1.29%

ACHL -3.19%

ACHV 3.02%

ACIU -1.50%

ACLX 0.37%

ACRV -5.61%

ACST -4.89%

ACXP 3.92%

ADAG 6.07%

ADAP -3.29%

ADGI 0.87%

ADIL 0.88%

ADMA -1.86%

ADPT 0.89%

ADTX -2.78%

ADVM 1.01%

ADXN -1.60%

AEON -2.80%

AEZS -2.49%

AFMD -1.92%

AGEN -3.30%

AGIO -2.01%

AGLE 6.66%

AGTC 0.00%

AIKI 0.85%

AIMDW -13.88%

AKBA 5.35%

AKRO -2.89%

AKTX -2.38%

AKUS 0.00%

ALBO 0.00%

ALDX -1.95%

ALEC -0.80%

ALGS 1.32%

ALKS 1.57%

ALLK -11.44%

ALLO -4.16%

ALLR -2.64%

ALNA 3.16%

ALNY 2.90%

ALPN 0.02%

ALPX 0.00%

ALRN -2.24%

ALT -13.69%

ALVR -0.67%

ALXN 0.00%

ALXO -13.63%

ALZN 4.02%

AMRN -1.76%

AMTI -3.13%

ANAB 1.47%

ANEB 3.13%

ANGN 0.00%

ANIX -3.04%

ANL -0.14%

ANNX 2.17%

ANPC -3.15%

APGE 0.13%

APGN 8.48%

APGNW 30.65%

APLM -5.82%

APLS 0.84%

APLT -0.90%

APM 1.26%

APOP 0.38%

APRE 0.84%

APTO 4.82%

APTX 3.17%

APVO 0.93%

ARAV -13.39%

ARCT -5.44%

ARDS -12.13%

ARDX 1.25%

ARGX -0.50%

ARNA 0.00%

ARPO -0.90%

ARQT -2.76%

ARTL -2.50%

ARTLW 0.00%

ARVN 6.70%

ARWR -1.56%

ASLN -3.24%

ASMB -4.22%

ASND -2.17%

ATAI -3.33%

ATHA 7.31%

ATHE 0.56%

ATHX -33.50%

ATNF 0.99%

ATOS 5.34%

ATRA -3.48%

ATXI 2.70%

ATXS -0.55%

AUPH -0.90%

AURA 4.55%

AUTL -3.02%

AVBP -3.35%

AVEO 0.00%

AVIR -2.33%

AVRO -1.41%

AVTE 0.35%

AVTX -3.74%

AVXL -4.94%

AXLA 0.00%

AXSM -1.21%

AYLA 0.00%

AZRX 2.07%

BBI 2.17%

BBIO 2.40%

BCAB -1.63%

BCDA -3.15%

BCDAW -41.77%

BCEL 0.00%

BCLI 4.21%

BCRX 1.89%

BCTX 8.16%

BCTXW 13.02%

BCYC 0.90%

BDRX -3.13%

BDTX 0.21%

BEAM 2.64%

BFRA -2.91%

BGNE -2.24%

BIOR -5.27%

BIVI 3.03%

BLCM -6.68%

BLI -5.88%

BLPH 0.00%

BLRX -3.39%

BLTE -1.03%

BLU 0.03%

BLUE -1.97%

BMEA -12.87%

BMRN 0.49%

BNOX 6.15%

BNTC -1.69%

BNTX -1.64%

BOLD -8.35%

BOLT -0.09%

BPMC -1.33%

BPTH -1.90%

BPTS -13.47%

BRNS -0.37%

BRTX -6.10%

BTAI 16.53%

BTTX 20.00%

BTX 0.05%

BVXV 0.74%

BXRX 7.39%

BYSI 2.97%

CABA 0.97%

CADL 0.71%

CALA 0.00%

CALC -3.74%

CALT -1.59%

CAPR -1.08%

CARA -3.26%

CARM 6.96%

CASI -1.65%

CATB -6.97%

CBAY 0.03%

CBIO -2.65%

CBLI -7.31%

CBUS 0.56%

CCCC -2.23%

CCXI 0.00%

CDAK 0.00%

CDIO -5.08%

CDIOW 24.00%

CDMO -1.55%

CDMOP 0.04%

CDT -0.81%

CDTTW -39.60%

CDTX -4.77%

CDXC 7.17%

CDXS 9.31%

CELC -3.03%

CELU -1.67%

CELUW 11.80%

CERC -1.68%

CERE -1.85%

CERO -9.53%

CEROW -10.18%

CFRX -27.95%

CGEM -0.12%

CGEN -3.31%

CGON -1.72%

CGTX -4.35%

CHMA -6.00%

CHRS 4.11%

CINC 0.00%

CING -2.56%

CINGW 34.95%

CKPT -1.79%

CLBS -16.75%

CLDX -0.88%

CLGN 0.70%

CLLS -3.63%

CLNN -2.62%

CLNNW 0.00%

CLRB 6.67%

CLSD -2.40%

CLSN -0.68%

CLVS 0.00%

CMMB -3.89%

CMND 8.07%

CMPI 0.00%

CMPX -0.94%

CMRA 0.00%

CMRAW 33.33%

CMRX -4.42%

CNCE 0.00%

CNSP -35.56%

CNST 0.00%

CNTA -0.11%

CNTB -0.75%

CNTX -4.79%

COCP -2.00%

COEPW 32.45%

COGT -2.04%

CORT 2.53%

COYA -0.64%

CPRX -1.91%

CRBP -0.48%

CRBU -6.82%

CRDF 1.55%

CRGX -0.03%

CRIS -3.19%

CRNX -6.05%

CRSP -0.22%

CRTX 2.63%

CRVO -2.20%

CRVS 0.56%

CSBR 0.11%

CTCX -1.59%

CTIC 0.06%

CTMX -3.31%

CTNM 1.98%

CTXR 0.36%

CUE -1.73%

CVAC -8.04%

CVKD -2.34%

CWBR 2.80%

CYAD -12.96%

CYCC 8.49%

CYCCP 5.28%

CYCN 7.81%

CYT -2.27%

CYTK -2.51%

CYTO 0.91%

DARE 3.54%

DAWN -0.90%

DBTX -0.81%

DBVT 4.17%

DFFN 10.28%

DICE 0.06%

DMAC 28.76%

DNLI -1.74%

DNTH -4.37%

DOMH 1.59%

DRMA -2.57%

DRMAW -1.25%

DRNA 0.00%

DRTS 0.46%

DRTSW 0.00%

DRUG 1.43%

DSGN -2.42%

DTIL -0.24%

DYAI 9.68%

EARS -1.77%

EDIT -2.62%

EDSA 4.09%

EFTR 4.47%

EFTRW -53.85%

EIGR -9.21%

ELAB -3.01%

ELDN 8.82%

ELEV -1.66%

ELOX 10.77%

ELTX -5.15%

ELVN -1.91%

ELYM 4.60%

ENGN 0.87%

ENGNW 0.00%

ENLV 0.00%

ENOB 1.79%

ENSC 6.53%

ENTA 0.41%

ENTO -4.97%

ENTX -0.53%

ENVB 8.03%

EPIX -0.73%

EPRX -1.92%

EPZM 0.00%

EQ -0.89%

EQRX -2.09%

EQRXW 0.00%

ERAS -0.24%

ERNA -2.83%

ERYP 1.30%

ESLA 4.30%

ESLAW 16.64%

ETNB -3.56%

ETON 3.35%

ETTX 0.00%

EVAX -0.71%

EVGN 4.76%

EVLO 0.00%

EWTX -1.73%

EXAI -0.28%

EXEL 0.47%

EYEG -0.69%

EYEN 0.67%

EYPT 1.82%

FATE -11.42%

FBIO 0.86%

FBIOP 0.87%

FBLG -7.12%

FBRX -0.02%

FDMT -4.68%

FENC -2.27%

FGEN -9.83%

FHTX 8.02%

FIXX 0.77%

FMTX 0.00%

FNCH 0.00%

FOLD -1.47%

FREQ 4.76%

FRLN 0.15%

FRTX 0.00%

FSTX 0.00%

FTRE 0.98%

FULC 2.34%

FUSN 0.00%

FWBI 4.59%

FWP 0.00%

GALT -0.43%

GANX -2.31%

GBIO -2.30%

GBT 0.01%

GDTC 0.50%

GERN -3.10%

GHRS -3.72%

GLMD -4.09%

GLPG -1.56%

GLSI 4.97%

GLTO -3.31%

GLUE -3.43%

GLYC -11.68%

GMAB -0.27%

GMDA -18.25%

GMTX 0.00%

GNCA -85.71%

GNFT -2.60%

GNLX -4.42%

GNPX -2.86%

GNTA 3.94%

GOSS -10.65%

GOVX -0.92%

GOVXW 10.89%

GPCR -6.14%

GRAY -10.80%

GRCL 0.05%

GRNA -0.03%

GRNAW 8.91%

GRPH -2.75%

GRTS -0.38%

GRTX -1.66%

GTHX 0.68%

GUTS 3.00%

GXGXW 41.67%

GYRE -4.54%

HALO -1.70%

HARP 0.09%

HCWB -6.13%

HEPA -3.62%

HGEN -84.62%

HILS 5.66%

HLVX -1.34%

HOOK 0.89%

HOTH -1.11%

HOWL 2.14%

HRMY 4.75%

HRTX 9.02%

HSTO 0.00%

HUMA 1.42%

HUMAW -6.26%

IBRX -5.30%

ICCC -4.42%

ICPT 0.21%

ICU 16.89%

ICUCW 20.20%

ICVX -0.91%

IDRA -23.04%

IDYA -3.02%

IFRX -2.77%

IGMS -1.32%

IKNA -0.30%

IKT -9.86%

IMAB 0.00%

IMCR -3.05%

IMGN 0.02%

IMGO 0.00%

IMMP 4.37%

IMMX -5.60%

IMNM 4.64%

IMNN 0.91%

IMPL -27.27%

IMRA 15.96%

IMRN -0.40%

IMRX -3.15%

IMTX -0.92%

IMTXW 6.00%

IMUX 1.85%

IMV 0.00%

IMVT -3.33%

INAB -1.66%

INBX -2.05%

INCY -2.28%

INDP 8.49%

INFI -52.38%

INKT 2.10%

INM -0.23%

INMB 4.18%

INO 3.12%

INSM -1.02%

INTS -1.96%

INVA 0.15%

INZY 2.06%

IOBT -10.94%

IONS 1.26%

IOVA -2.54%

IPA 3.00%

IPHA 3.05%

IPSC -2.34%

IRON -2.34%

ISEE 0.38%

ITOS 0.82%

ITRM 2.33%

IVA 6.96%

IVVD -0.41%

JAGX 1.31%

JANX -4.24%

JAZZ -1.00%

JNCE 0.00%

JSPR -1.60%

JSPRW 20.88%

JUNS 0.00%

JUNSW 0.00%

KA -2.45%

KALV -3.90%

KDNY 0.22%

KMPH -0.34%

KNSA -2.06%

KNTE -0.38%

KOD -7.51%

KPRX -4.81%

KPTI -7.80%

KRBP -10.00%

KRON 1.16%

KROS -0.21%

KRRO -2.26%

KRTX 0.03%

KRYS 0.38%

KTRA 11.71%

KTTA -0.65%

KTTAW 0.92%

KURA 0.24%

KYMR -2.87%

KYTX -3.23%

KZIA 4.41%

KZR -0.12%

LABP 0.57%

LBPH -0.30%

LBPS 0.00%

LBPSW 14.81%

LEGN 1.01%

LENZ -3.28%

LEXX -1.16%

LEXXW -14.63%

LGND -1.29%

LGNDV 0.00%

LGVN -9.04%

LIAN -8.28%

LIFE 2.70%

LIPO -5.10%

LIXT -9.76%

LIXTW 46.21%

LJPC -0.32%

LMNL 0.12%

LOGC 1.48%

LPCN -3.68%

LPTX -2.47%

LQDA 0.49%

LRMR 0.78%

LSTA -1.68%

LTRN 5.02%

LUMO 1.79%

LVTX -2.58%

LXEO -8.39%

LXRX -1.77%

LYEL -35.05%

LYRA 1.94%

MACK 0.10%

MBIO -11.74%

MBRX -1.43%

MCRB 3.05%

MDGL -2.08%

MDNA -13.16%

MDWD 3.56%

MDXG -2.21%

MEIP 0.00%

MESO -1.49%

MGNX -4.32%

MGTA -7.74%

MGTX -0.83%

MGX 2.54%

MIRM 0.03%

MIRO 0.59%

MIST 2.66%

MITO 0.00%

MLEC -7.68%

MLECW 2.31%

MLND -5.36%

MLTX 0.28%

MLYS -5.87%

MNKD -0.48%

MNMD 4.53%

MNOV 2.11%

MNPR -8.56%

MOLN 2.20%

MOR 0.45%

MORF -3.16%

MREO -2.43%

MRKR -0.43%

MRNA -8.89%

MRNS -5.51%

MRSN -2.86%

MRTX -0.17%

MRUS -0.75%

MRVI -0.73%

MTCR -1.29%

MTEM 6.93%

MTP -18.50%

MURA -4.02%

MYMD 1.08%

NAMS -0.65%

NAMSW -0.21%

NAUT 1.33%

NBRV 0.71%

NBSE -1.56%

NBTX 12.09%

NCNA 0.00%

NERV -1.58%

NEXI -0.74%

NGM -1.28%

NGNE 3.70%

NKGN 10.09%

NKGNW 8.00%

NKTR 4.21%

NKTX -4.24%

NLSP 3.53%

NLSPW 26.67%

NMRA -1.03%

NMTR -42.97%

NOVN -24.84%

NRBO 19.72%

NRIX -0.58%

NRSN -4.82%

NRSNW 0.00%

NRXP -7.81%

NRXPW 18.33%

NRXS -1.20%

NTBL 2.63%

NTEC -12.45%

NTHI 0.00%

NTLA -5.21%

NTRBW -31.07%

NUVL -1.23%

NVAX -7.18%

NVCT -7.75%

NVIV -34.28%

NXTC -3.53%

NYMX -0.05%

OABI 2.77%

OABIW -10.06%

OBIO -1.17%

OBSV 0.00%

OCEA -2.11%

OCGN 9.35%

OCS -1.00%

OCUL 0.91%

OCUP 0.65%

ODT -4.27%

OKYO 2.15%

OLMA -5.03%

OMER -2.83%

OMGA 0.41%

ONCO 5.89%

ONCR -3.08%

ONCS 31.87%

ONCT -2.35%

ONCY 4.00%

ONTX -0.47%

ONVO 0.29%

OPNT 0.00%

OPT 2.06%

ORGS 1.19%

ORIC -1.34%

ORMP 18.30%

ORPH 0.00%

ORTX 0.30%

OSMT -1.77%

OTIC -92.64%

OTLK -1.18%

OVID 0.01%

OYST 0.00%

PALI -0.22%

PASG 2.63%

PBLA -7.50%

PBM -4.70%

PBYI 2.87%

PCSA -1.93%

PCVX 0.07%

PDSB -6.17%

PEPG 1.37%

PGEN -5.99%

PHAR 2.19%

PHAS 0.00%

PHAT -0.10%

PHIO -3.58%

PHIOW 36.47%

PHVS -5.83%

PHXM -5.20%

PIRS 0.58%

PKBO 0.00%

PKBOW 999 900.00%

PLRX -2.01%

PLUR 7.39%

PMN -5.55%

PMVP -2.38%

PNT 0.16%

PPBT -6.43%

PRAX 6.88%

PRDS 0.93%

PRLD -2.64%

PROG -3.47%

PROK -0.45%

PRQR 1.21%

PRTA -2.50%

PRTC 0.62%

PRTG 1.00%

PRTK 1.83%

PRVB 0.00%

PSTI -2.91%

PSTV -14.04%

PSTX -2.71%

PTCT -0.57%

PTE -0.82%

PTGX -0.87%

PTIXW -48.41%

PULM 1.53%

PXMD 4.76%

PYPD 1.71%

PYXS 4.58%

QLGN -7.18%

QNCX 5.70%

QNRX -0.49%

QSI -36.44%

QSIAW -3.13%

QTTB 1.08%

QURE -0.34%

RAIN -1.63%

RANI 4.81%

RAPT -1.61%

RARE 1.86%

RCKT -9.01%

REGN -0.41%

RENB -3.43%

REPL -1.36%

RETA 0.02%

REUN -0.89%

REVB -1.40%

REVBU 3.46%

REVBW 5.00%

RGLS -5.14%

RGNX -6.34%

RIGL -6.36%

RLAY -4.46%

RLMD 0.00%

RLYB -4.38%

RNA 1.19%

RNAC -4.62%

RNAZ 0.00%

RNXT 0.89%

ROIV -1.62%

ROIVW 4.56%

RPHM -0.93%

RPRX -0.65%

RPTX -0.59%

RUBY 2.70%

RVLP -32.05%

RVMD -0.50%

RVMDW -29.90%

RVNC -0.64%

RVPH -1.58%

RVPHW -5.28%

RXDX 0.09%

RXRX -5.81%

RYTM -5.68%

RYZB 0.02%

RZLT 2.58%

SABS -1.37%

SABSW -11.81%

SAGE 0.46%

SANA -2.77%

SAVA -1.35%

SAVAW 0.00%

SBBP 1.52%

SBTX 1.03%

SCNI 2.65%

SCPH 10.10%

SCPS 0.00%

SEEL -4.85%

SEER 0.00%

SELB -8.00%

SESN 7.29%

SGEN -0.07%

SGMO -1.46%

SGMT -4.95%

SGTX -2.56%

SIOX 22.63%

SLDB -2.76%

SLGL 5.23%

SLN -7.27%

SLNO 0.23%

SLRX 1.23%

SLS -3.40%

SMMT -3.50%

SNDX 3.10%

SNGX -0.38%

SNPX -2.56%

SONN -1.08%

SPPI -0.49%

SPRB -1.59%

SPRC -4.25%

SPRO 0.75%

SRNE 0.00%

SRPT -1.15%

SRRA 0.00%

SRRK -1.42%

SRZN -2.45%

STAB 0.00%

STOK -6.81%

STRO -1.67%

STSA 0.00%

STTK 5.77%

SURF -0.93%

SVRA -1.45%

SWTX 0.11%

SYBX 1.29%

SYRS -2.15%

TALS -0.73%

TARA -7.38%

TARS -1.92%

TBPH 0.77%

TCBP 5.56%

TCDA 0.00%

TCON 0.00%

TCRR 0.00%

TCRT -1.75%

TCRX 4.52%

TECH -0.77%

TENX -0.32%

TERN -8.99%

TFFP -7.61%

TGTX -7.03%

THRX 0.12%

TIL -1.09%

TLC 0.00%

TLSA -7.23%

TNGX -3.24%

TNXP -5.60%

TNYA -4.73%

TPST 5.74%

TRDA -4.67%

TRVI 2.68%

TRVN 0.82%

TSHA -19.96%

TSVT -4.26%

TTNP -6.05%

TVTX 3.02%

TYRA -6.95%

UBX -2.55%

UNCY -3.82%

URGN 2.55%

UTHR -0.06%

VACC 11.36%

VALN -6.70%

VAXX 118.69%

VBIV 0.93%

VBLT -8.77%

VCEL 1.04%

VCNX 9.03%

VCYT -0.70%

VERA -5.79%

VERU 1.03%

VERV -2.29%

VIGL -0.54%

VINC 2.99%

VIR -0.49%

VIRI -4.53%

VIRX 3.98%

VKTX -1.63%

VLON -13.04%

VNDA -3.99%

VOR -6.05%

VRCA 0.35%

VRDN -3.29%

VRNA -1.26%

VRPX 1.02%

VRTX 0.07%

VSTM 3.25%

VTGN -1.66%

VTVT 0.39%

VTYX -2.30%

VXRT -2.32%

VYGR -0.77%

VYNE -5.17%

VYNT 7.78%

WINT -0.60%

WVE -8.18%

XBIO 1.03%

XBIT 7.29%

XCUR 3.77%

XENE -1.97%

XERS 5.00%

XFOR 5.73%

XLO 4.42%

XLRN 0.00%

XNCR 0.41%

XOMA -10.03%

XOMAO -0.45%

XOMAP -0.82%

XRTX -7.96%

YMAB -1.31%

ZGNX 0.00%

ZIOP -0.88%

ZLAB -3.62%

ZNTL -1.79%

ZSAN 0.00%

Insider Trading

Date	Person	Action	Amount	type
2024-05-01	Hahn Mark W	Sell	88 544	Ordinary Shares
2024-05-01	Rickard Kathleen A.	Sell	73 824	Ordinary Shares
2024-05-03	Rickard Kathleen A.	Sell	36 248	Ordinary Shares
2024-05-01	Zaccardelli David	Sell	88 544	Ordinary Shares
2024-04-29	Sinha Vikas	Buy	240 000	Share Options (Right to Buy)

INSIDER POWER
14.81
Last 97 transactions
Buy: 8 767 528 \| Sell: 8 544 730

Correlación (AI algo v.1.1b): Overvalued: -0.79% $14.88 paired level. (El Algoritmo Rastrea Los Cambios De Las Acciones Más Correlacionadas En Tiempo Real Y Proporciona Una Actualización Instantánea)

Volumen Correlación

Largo: -0.11 (neutral)

Corto: 0.60 (weak)

Signal:(46.189) Neutral

Verona Pharma plc Correlación

10 Correlaciones Más Positivas
AUGX	0.911
JOUT	0.906
KLXE	0.898
VOXX	0.895
FWRD	0.891
PACB	0.891
EGBN	0.886
SVC	0.883
NYMT	0.88
AVXL	0.878

10 Correlaciones Más Negativas
BSCO	-0.915
ADMA	-0.887
ACGL	-0.886
XFIN	-0.882
GOGL	-0.879
IGTA	-0.878
ESTA	-0.876
MDWD	-0.873
INBKZ	-0.872
APXI	-0.872

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Verona Pharma plc Correlación - Moneda/Commodity

-0.17
( neutral )

-0.38
( neutral )

0.00
( neutral )

-0.25
( neutral )

0.00
( neutral )

-0.38
( neutral )

Verona Pharma plc Finanzas

Annual	2023
Ingresos:	$0
Beneficio Bruto:	$-679 624 (0.00 %)
EPS:	$-0.690

FY	2023
Ingresos:	$0
Beneficio Bruto:	$-679 624 (0.00 %)
EPS:	$-0.690

FY	2022
Ingresos:	$458 000
Beneficio Bruto:	$112 000 (24.45 %)
EPS:	$-1.040

FY	2021
Ingresos:	$40.00M
Beneficio Bruto:	$0.00 (0.00 %)
EPS:	$-0.960

Financial Reports:

No articles found.

Verona Pharma plc Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Verona Pharma plc

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. Verona Pharma plc was incorporated in 2005 and is headquartered in London, the United Kingdom.